Investment Rating - The investment rating for the company is "Accumulate" [7] Core Insights - The company has announced its 2026 investment plan and the "8462 Leap Action - 14th Five-Year Plan," clarifying its growth direction for the future [1] - The company aims to enhance its "digital intelligence" capabilities and accelerate the layout of the oral health ecosystem, with planned investments of approximately 113 million yuan, including 63 million yuan in fixed assets and 50 million yuan in equity investments [2] - The company has set ambitious goals to double both revenue and total profit during the 14th Five-Year Plan, focusing on four key areas: oral care, smart oral health, oral medical services, and innovative businesses [3] - The company is expected to recover online investments and achieve a strong start in the 14th Five-Year Plan, with a focus on new product launches and optimizing product structure [4] - The company is a leader in the sensitive toothpaste market and is expected to see substantial growth through product upgrades and diversification, with projected revenues of 1.75 billion yuan, 2.11 billion yuan, and 2.50 billion yuan for 2025, 2026, and 2027, respectively [5] Financial Summary - The company forecasts revenues of 1.75 billion yuan for 2025, with a year-on-year growth of 12.20%, and net profits of 181 million yuan, reflecting a growth of 12.50% [11] - For 2026, the expected revenue is 2.11 billion yuan, with a growth rate of 20.67%, and net profit is projected at 219 million yuan, a 20.96% increase [11] - By 2027, the company anticipates revenues of 2.50 billion yuan, with an 18.43% growth, and net profits of 263 million yuan, reflecting a 19.89% increase [11]